Müschen, Markus
Article History
First Online: 5 January 2018
Competing interests
: Research in M.M.'s laboratory to elucidate the mechanisms of autoimmunity checkpoints concept activation in B cell malignancies and feasibility of drug-targeting is currently supported by research funding from AbbVie Inc. and Pfizer.